Stigma and the use of anabolic androgenic steroids by men in the united kingdom

J McVeigh, G Bates - Drugs, identity and stigma, 2022 - Springer
The use of anabolic androgenic steroids (AAS) has diffused from elite sport and competitive
bodybuilding and is now commonplace in the gyms of the UK. People who use AAS are by …

A sentinel population: The public health benefits of monitoring enhanced body builders

J McVeigh, M Salinas, R Ralphs - International Journal of Drug Policy, 2021 - Elsevier
There is heightened recognition of the public health implications of anabolic androgenic
steroids (AAS) for the use of image and performance enhancement; with increasing …

Supraphysiological testosterone levels from anabolic steroid use and reduced sensitivity to negative facial expressions in men

M Scarth, LE Hauger, PM Thorsby, S Leknes… - …, 2024 - Springer
Rationale Anabolic-androgenic steroids (AAS) are used to improve physical performance
and appearance, but have been associated with deficits in social cognitive functioning …

Use of high-dose androgens is associated with reduced brain-derived neurotrophic factor in male weightlifters

A Bjørnebekk, M Scarth, SP Neupane, LT Westlye… - …, 2023 - karger.com
Introduction: Use of high-dose androgens causes drastic changes in hormonal milieu and is
associated with adverse medical, psychological, and cognitive effects. Brain-derived …

[HTML][HTML] Double trouble? A mixed methods study exploring experiences with combined use of anabolic-androgenic steroids and psychoactive substances among …

IA Havnes, ML Jørstad, A Bjørnebekk - Performance Enhancement & Health, 2021 - Elsevier
Concurrent use of anabolic-androgenic steroids (AAS) and psychoactive substances (illicit
drugs and alcohol) is found common in studies among men and involves a higher risk of …

[HTML][HTML] Two sides of the same coin: A qualitative exploration of experiential and perceptual factors which influence the clinical interaction between physicians and …

NP Ainsworth, SN Thrower, A Petroczi - Emerging Trends in Drugs …, 2022 - Elsevier
Background Patient-physician interactions involve complex interplays between patient and
physician autonomy. This is intensified in stigmatised populations, such as anabolic …

Lääkkeiden väärinkäytön tunnistaminen ja hoito

M Häkkinen, H Särkilä, A Stenius-Ayoade… - …, 2023 - researchportal.helsinki.fi
Suurin osa suomalaisista käyttää reseptilääkkeitään vailla päihtymystarkoitusta, ja vain 2%
on väärinkäyttänyt niitä viimeksi kuluneen vuoden aikana. Yleisimpiä väärinkäytettyjä …

Female doping: observations from a data lake study in the Hospital District of Helsinki and Uusimaa, Finland

PK Vauhkonen, TD Laajala, KM Lindroos… - BMC Women's …, 2023 - Springer
Background Doping is a well-recognized risk factor for several potentially severe health
effects. Scientific literature concerning the need for medical treatment for such adversities is …

Organ pathologies detected post‐mortem in patients receiving opioid agonist treatment for opioid use disorder: a nation‐wide 2‐year cross‐sectional study

AB Bech, T Clausen, H Waal, GJM Delaveris… - Addiction, 2022 - Wiley Online Library
Aims To document organ pathologies detected post‐mortem in patients receiving opioid
agonist treatment for opioid use disorder and estimate the extent to which individual …

[HTML][HTML] Clomiphene citrate and optional human chorionic gonadotropin for treating male hypogonadism arising from long-term anabolic-androgenic steroid use—A …

HCB Henriksen, AP Jørgensen, A Bjørnebekk… - … Enhancement & Health, 2024 - Elsevier
Introduction Long-term anabolic-androgenic steroid (AAS) use poses several health risks,
including secondary hypogonadism. There is a knowledge gap on treatment targeting the …